Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Diumide-K Continus tablets
0202080K0BCAAAB
|
Diumide-K Continus | Furosemide/potassium | Cardiovascular System | No data available |
|
Furosemide 20mg/Pot chlor 750mg (pot 10mmol) MR tab
0202080K0AAAAAA
|
Furosemide/potassium | Furosemide/potassium | Cardiovascular System | No data available |
|
Furosemide 40mg/Pot chlor 600mg (pot 8mmol) MR tab
0202080K0AAABAB
|
Furosemide/potassium | Furosemide/potassium | Cardiovascular System | No data available |
|
Lasikal modified-release tablets
0202080K0BBAAAA
|
Lasikal | Furosemide/potassium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.